ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models

BACKGROUND: Despite current therapies, glioblastoma is a devastating cancer, and validation of effective biomarkers for it will enable better diagnosis and therapeutic intervention for this disease. We recently discovered a new biomarker for high-grade gliomas, ELTD1 (epidermal growth factor, latrop...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Ziegler, Jadith, Pody, Richard, Coutinho de Souza, Patricia, Evans, Blake, Saunders, Debra, Smith, Nataliya, Mallory, Samantha, Njoku, Charity, Dong, Yunzhou, Chen, Hong, Dong, Jiali, Lerner, Megan, Mian, Osamah, Tummala, Sai, Battiste, James, Fung, Kar-Ming, Wren, Jonathan D., Towner, Rheal A.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Basic and Translational Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464087/
https://ncbi.nlm.nih.gov/pubmed/27416955
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now147
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados